Long before September 11th and fears of a bio-terrorism attack, a Harvard researcher began work on an Anthrax solution.
His research identified a gene that in mice blocked the bacteria's dangerous path, making the mice immune to Anthrax-produced toxins.
"Unfortunately, this disease, once you've recognized the symptoms in an individual, it's often very difficult to treat even with very good antibiotics," said Dr. William Dietrich, from Harvard Medical School.
The next challenge is finding out if the gene can protect humans. The study appears in this month's issue of Current Biology .